DKSH opens new distribution healthcare center in South Korea

 

DKSH, the leading Market Expansion Services provider with a focus on Asia, inaugurates a new healthcare distribution center in Seoul today.
 
Seoul, Korea - DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, officially opened today its 4,300 square meter state-of-the-art healthcare distribution center in Seoul. DKSH welcomed representatives of key clients at the opening ceremony. 
 
With its strategic location, nearby key hospitals in Seoul, the distribution center will manage mainly medical devices that regularly require emergency deliveries. With a capacity of over 20,000 stock-keeping units (SKUs), the distribution center will also handle medical supplies and pharmaceutical products and serve several hundred healthcare customers including hospitals, clinics and pharmacies in the capital area. 
 
In line with DKSH Healthcare's dedication to quality and compliance, the distribution center complies with Korean Good Supplying Practices (KGSP) and adheres to international quality standards ISO 9001 and ISO 13485. With dedicated cold chain and redressing facilities, as well as advanced around-the-clock monitoring and security systems, the distribution center enables DKSH to provide its business partners with seamless and integrated services tailored to their needs. 
 
"The new distribution center underlines our commitment to continue our investment and growth in Korea. It will increase operational efficiencies, enhance our capabilities and drive our business expansion", said Charles Toomey, Head Business Unit Healthcare at DKSH. 
 
Joo-Hwan Han, General Manager Business Unit Healthcare at DKSH Korea, added: "Our new distribution center complements our existing healthcare distribution centers in Korea and will support the enhancement of our capabilities to better support the growth of our clients and customers in the country. Focusing on medical devices, the distribution center will help DKSH to strengthen its position as partner of choice for medical devices companies who want to expand their business in Korea."
 
About DKSH
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets.
 
Publicly listed on the SIX Swiss Exchange since March 2012, DKSH is a global company headquartered in Zurich. With 680 business locations in 35 countries – 660 of them in Asia – and 25,900 specialized staff, DKSH generated net sales of CHF 8.8 billion in 2012.
 
DKSH Business Unit Healthcare is the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia. Custom-made offerings comprise registration and market entry studies as well as importation, customs clearance, marketing and sales to physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include ethical pharmaceuticals, consumer health, over-the-counter (OTC), as well as medical devices. With 150 business locations in 13 countries and around 8,270 specialized staff, Business Unit Healthcare serves over 160,000 customers and generated net sales of around CHF 3.7 billion in 2012.

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.